Correction to “In-Gel Generated Palladium Nanostructures as Bioorthogonal Uncaging Reactors”

IF 4.8 Q2 ENGINEERING, BIOMEDICAL

Advanced Nanobiomed Research Pub Date : 2026-01-06 Epub Date: 2025-12-12 DOI:10.1002/anbr.70087

Aisling McGuigan, Víctor Sebastián, Asier Unciti-Broceta, Jesús Santamaría, Ferry Melchels

{"title":"Correction to “In-Gel Generated Palladium Nanostructures as Bioorthogonal Uncaging Reactors”","authors":"Aisling McGuigan, Víctor Sebastián, Asier Unciti-Broceta, Jesús Santamaría, Ferry Melchels","doi":"10.1002/anbr.70087","DOIUrl":null,"url":null,"abstract":"Adv. NanoBiomed Res., 2025, 5(11), 2500118https://doi.org/10.1002/anbr.202500118Figures 4 and 5 have been updated.The third paragraph under the section “2.3. Release of sequestered dye product from Pd-laden hydrogels” has been updated:The proportion of sequestered dye released from pHEMA–GG discs significantly increased from 12.6% to 17.9% to 21.1% (averaged over both thicknesses and Pd nanoshapes) when exposure time to proresorufin increased from 0.5 to 1 to 2 hours (p < 0.0001). For the pHEMA–co–AM copolymers, the increase from 16.3% after 0.5 hours to 18.3% after 1 hours was smaller but still significant (p = 0.0001), whereas the increase to 18.6% at 2 hours was not (p = 0.8, Figure 5).The section “5.10. Statistics” has been updated.All values are reported as average ± standard deviation unless indicated otherwise. Reported p-values for head-to-head comparisons are obtained from two-tailed homoscedastic Student's T-test (MS Excel). ANOVA with Tukey's post-hoc test was performed between time-points, for pHEMA-GG and pHEMA-co-AM polymers separately (MS Excel). Groups that share a letter (and case) are not statistically significantly different. Decreasing trends were tested for statistical significance using a Mann-Kendall test (XLSTAT).","PeriodicalId":29975,"journal":{"name":"Advanced Nanobiomed Research","volume":"6 1","pages":""},"PeriodicalIF":4.8000,"publicationDate":"2026-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://advanced.onlinelibrary.wiley.com/doi/epdf/10.1002/anbr.70087","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advanced Nanobiomed Research","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/anbr.70087","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/12/12 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}

引用次数: 0

Abstract

Adv. NanoBiomed Res., 2025, 5(11), 2500118

https://doi.org/10.1002/anbr.202500118

Figures 4 and 5 have been updated.

The third paragraph under the section “2.3. Release of sequestered dye product from Pd-laden hydrogels” has been updated:

The proportion of sequestered dye released from pHEMA–GG discs significantly increased from 12.6% to 17.9% to 21.1% (averaged over both thicknesses and Pd nanoshapes) when exposure time to proresorufin increased from 0.5 to 1 to 2 hours (p < 0.0001). For the pHEMA–co–AM copolymers, the increase from 16.3% after 0.5 hours to 18.3% after 1 hours was smaller but still significant (p = 0.0001), whereas the increase to 18.6% at 2 hours was not (p = 0.8, Figure 5).

The section “5.10. Statistics” has been updated.

All values are reported as average ± standard deviation unless indicated otherwise. Reported p-values for head-to-head comparisons are obtained from two-tailed homoscedastic Student's T-test (MS Excel). ANOVA with Tukey's post-hoc test was performed between time-points, for pHEMA-GG and pHEMA-co-AM polymers separately (MS Excel). Groups that share a letter (and case) are not statistically significantly different. Decreasing trends were tested for statistical significance using a Mann-Kendall test (XLSTAT).

Abstract Image

查看原文本刊更多论文

对“凝胶生成的钯纳米结构作为生物正交脱壳反应器”的修正

纳米生物学报，2025,5(11),2500118https://doi.org/10.1002/anbr.202500118Figures 4和5已更新。“2.3”节下的第三段。从负载Pd的水凝胶中释放的隔离染料产品已经更新：phma - gg圆盘释放的隔离染料比例显着从12.6%增加到17.9%到21.1%（在厚度和Pd纳米形状上的平均值），当暴露于间苯二酚的时间从0.5小时增加到1到2小时（p < 0.0001）。对于pHEMA-co-AM共聚物，0.5小时后从16.3%增加到1小时后18.3%的幅度较小，但仍然显著（p = 0.0001），而2小时后增加到18.6%则没有（p = 0.8，图5）。第5.10节。“统计数字”已更新。除非另有说明，所有数值均以平均值±标准差报告。头对头比较的报告p值来自双尾均方差学生t检验（MS Excel）。在时间点之间分别对pHEMA-GG和pHEMA-co-AM聚合物进行Tukey事后检验的方差分析（MS Excel）。相同字母（和大小写）的组在统计上没有显著差异。使用Mann-Kendall检验（XLSTAT）对下降趋势进行统计学显著性检验。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Advanced Nanobiomed Research nanomedicine, bioengineering and biomaterials-

CiteScore

5.00

自引率

5.90%

发文量

审稿时长

21 weeks

期刊介绍： Advanced NanoBiomed Research will provide an Open Access home for cutting-edge nanomedicine, bioengineering and biomaterials research aimed at improving human health. The journal will capture a broad spectrum of research from increasingly multi- and interdisciplinary fields of the traditional areas of biomedicine, bioengineering and health-related materials science as well as precision and personalized medicine, drug delivery, and artificial intelligence-driven health science. The scope of Advanced NanoBiomed Research will cover the following key subject areas: ▪ Nanomedicine and nanotechnology, with applications in drug and gene delivery, diagnostics, theranostics, photothermal and photodynamic therapy and multimodal imaging. ▪ Biomaterials, including hydrogels, 2D materials, biopolymers, composites, biodegradable materials, biohybrids and biomimetics (such as artificial cells, exosomes and extracellular vesicles), as well as all organic and inorganic materials for biomedical applications. ▪ Biointerfaces, such as anti-microbial surfaces and coatings, as well as interfaces for cellular engineering, immunoengineering and 3D cell culture. ▪ Biofabrication including (bio)inks and technologies, towards generation of functional tissues and organs. ▪ Tissue engineering and regenerative medicine, including scaffolds and scaffold-free approaches, for bone, ligament, muscle, skin, neural, cardiac tissue engineering and tissue vascularization. ▪ Devices for healthcare applications, disease modelling and treatment, such as diagnostics, lab-on-a-chip, organs-on-a-chip, bioMEMS, bioelectronics, wearables, actuators, soft robotics, and intelligent drug delivery systems. with a strong focus on applications of these fields, from bench-to-bedside, for treatment of all diseases and disorders, such as infectious, autoimmune, cardiovascular and metabolic diseases, neurological disorders and cancer; including pharmacology and toxicology studies.